Suppr超能文献

[病理组织学I期子宫内膜癌术后放疗的价值]

[The value of postoperative irradiation in endometrial cancer of pathohistologic stage I].

作者信息

Kucera H, Vavra N, Weghaupt K

机构信息

Ordinariat für Gynäkologische Strahlentherapie der Universität Wien.

出版信息

Geburtshilfe Frauenheilkd. 1989 Jul;49(7):618-24. doi: 10.1055/s-2008-1026666.

Abstract

In a prospective therapeutic study, 571 cases of endometrial cancer in pathological stage I were treated initially with total hysterectomy and received 6 weeks after surgery double high-dose-rate iridium 192 irradiation of the vagina (afterloading technique). The single dose was 700 cGY (at 2 cm distance from the applicator axis). Postoperative treatment planning was based on the prognosticators of depth of myometrial invasion and tumor grading with subtypes. External irradiation was prescribed only for patients with poor prognostic factors (Cobalt-60,5600 cGY on the pelvis wall, 30 fractions). At the time of this report, the patients had been followed up for 6 to 96 months after their original therapy. Survival was calculated by the life table method. 327 cases with slight tumor infiltration, independent of the tumor morphology, received postoperative vaginal irradiation only. Survival rate was 90.6%. 27 cases with tumor infiltration of the middle third of the myometrium and grade 1 tumors, received also only vaginal irradiation. Survival rate was 100%. 101 cases with tumor infiltration of the middle third of the myometrium and grade 2 and 3 tumors, received vaginal irradiation plus external irradiation. Survival rate was 89.9%. 116 cases with tumor infiltration of the external third of the mymetrium and any tumor grade, received vaginal irradiation plus also external irradiation. In these patients with poor prognosis, the survival rate was 85%. Differences between groups are not significant. Considering the treatment group with good prognosis and the group with poorer prognosis and the additional external irradiation, the survival figures were quite similar (90.6% and 87.9% respectively). In spite of the unfavorable situation of patients with poor prognosticators, treatment results after the additional external irradiation were rather similar to those cases with good prognosticators and without external irradiation. The value of external irradiation in cases of endometrial cancer in stage I with unfavorable prognosticators seems to be quite clear. This therapy improvement was all the better, because side effects of external irradiation were low (0.2% rectovaginal fistulas) and in case of irradiation of the vagina only, no severe side effects occurred. Relapse rate for the treatment group with good prognosis and vaginal irradiation only was 0.6% (2 from 354) and for the group with poor prognosis and additional external irradiation 2.8% (6 from 217) respectively.

摘要

在一项前瞻性治疗研究中,571例病理分期为I期的子宫内膜癌患者首先接受了全子宫切除术,并在术后6周接受了双高剂量率铱192阴道照射(后装技术)。单次剂量为700 cGY(距施源器轴2 cm处)。术后治疗计划基于肌层浸润深度和肿瘤分级及亚型等预后因素。仅对预后不良因素的患者进行外照射(钴 - 60,盆腔壁5600 cGY,30次分割)。在本报告发布时,患者在初始治疗后已随访6至96个月。生存率采用生命表法计算。327例肿瘤浸润轻微的患者,无论肿瘤形态如何,仅接受术后阴道照射。生存率为90.6%。27例肌层中三分之一浸润且为1级肿瘤的患者,也仅接受阴道照射。生存率为100%。101例肌层中三分之一浸润且为2级和3级肿瘤的患者,接受阴道照射加外照射。生存率为89.9%。116例肌层外三分之一浸润且任何肿瘤分级的患者,接受阴道照射加外照射。在这些预后不良的患者中,生存率为85%。各组之间差异不显著。考虑预后良好的治疗组和预后较差且接受额外外照射的组,生存数据相当相似(分别为90.6%和87.9%)。尽管预后不良因素的患者情况不利,但额外外照射后的治疗结果与预后良好且未接受外照射的病例相当相似。对于具有不利预后因素I期子宫内膜癌患者,外照射的价值似乎相当明确。这种治疗改进更好,因为外照射的副作用较低(0.2%直肠阴道瘘),并且仅进行阴道照射时,未出现严重副作用。预后良好且仅接受阴道照射的治疗组复发率为0.6%(354例中有2例),预后较差且接受额外外照射的组复发率为2.8%(217例中有6例)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验